Emma Ebere
Corporate Officer/Principal bij Gemini Pharmaceuticals, Inc.
Oorsprong van het eerstegraads netwerk van Emma Ebere
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Gemini Pharmaceuticals, Inc.
 Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY.
5
| Private Company | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Emma Ebere via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| New York University | College/University | Undergraduate Degree | |
| Adelphi University | College/University | Undergraduate Degree | |
| University of Catania | College/University | Doctorate Degree | |
| University of California | College/University | Corporate Officer/Principal | |
| KINTARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| Theia Therapeutics, Inc. | Founder | ||
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Italië | 2 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 4 |
| Finance | 2 |
Operationeel
| Sales & Marketing | 2 |
| Undergraduate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| President | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Napoleone Ferrara | 8 |
| Joni Foley | 3 |
| Andrew Finamore | 1 |
| Michael Finamore | 1 |
| John Donovan | 1 |
- Beurs
- Insiders
- Emma Ebere
- Bedrijfsconnecties
